Hinova Pharma
VC Fund
Chengdu, China
Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptorinhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Hinova Pharma invests in
Stages Hinova Pharma invests in
Countries Hinova Pharma invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Frank Perabo
|
|||
Xinghai Li
|
|||
Yuanwei Chen
|
|||
Investment Focus
Industry
- Medical 1 (100%)
- Biopharma 1 (100%)
- Biotechnology 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Frank Perabo
Chief Medical Officer
|
Chief Medical Officer | Total investments: 0 | Find email | |
|
Xinghai Li
Co-Founder and Chief Scientific Officer
|
Co-Founder and Chief Scientific Officer | Total investments: 0 | Find email | |
|
Yuanwei Chen
Founder and Chief Executive Officer
|
Founder and Chief Executive Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hongxin Biology
|
Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development. | Angel / Dec 30, 2022 |
Co-Investors
Haiyuan Capital
1 deal together
Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Hinova Pharma invest in?
Hinova Pharma invests primarily in Medical, Biopharma and Biotechnology startups, most often at Angel stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Hinova Pharma?
Public channels for Hinova Pharma include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Hinova Pharma?
The team at Hinova Pharma includes Frank Perabo (Chief Medical Officer), Xinghai Li (Co-Founder and Chief Scientific Officer) and Yuanwei Chen (Founder and Chief Executive Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
